R&D Innovation

Hubei Hongyuan Pharmaceutical Technology Co., Ltd

R&D Innovation

We offer chemical synthesis and discovery support, grounded in rigorous scientific practice.

The company is a high-tech enterprise, an innovative enterprise in Hubei Province, and an intellectual property advantage enterprise in Hubei Province (patent category). It maintains close exchanges and good cooperation with well-known universities such as Fudan University, Wuhan University, Sichuan University, Wuhan Engineering University, Hubei University of Traditional Chinese Medicine, etc. R & D relationship, established provincial enterprise technology center, Hubei fluorine chemical engineering technology research center, Wuhan R & D center, formed a relatively complete technological innovation system.

Phase I
Molecular Synthesis

High-precision refinement of industrial precursor structures.

Phase II
Process Optimization

Scaling discovery-based manufacturing for global supply chains.

Phase III
Technical Validation

Rigorous purity verification under internationally recognized protocols.

Industrial R&D Excellence

Analytical Purity

Tier-1 molecular screening for specialized industrial consistency.

Custom Catalysts

Developing bespoke chemical solutions for niche manufacturing applications.

Safety Protocols

Integrated risk mitigation strategies in high-precision factory lines.

Global Logistics

Strategic supply chain alignment for reliable chemical fulfillment.

There are a number of independent intellectual property rights in raw materials and pharmaceutical intermediates, pharmaceutical preparations, new energy materials, etc., with 65 patents, including 57 invention patents, and innovative processes have won provincial scientific and technological progress awards for many times.